
Regeneron Pharmaceuticals, Inc (REGN) ticks all the boxes for top investors with its surprise performance of -18.12% last month.
Regeneron Pharmaceuticals, Inc (NASDAQ: REGN) kicked off on Friday, down -19.01% from the previous trading day, before settling in for the closing price of $605.39.